Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

1.540 +0.050 (+3.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,835,219
Open 1.460
Bid (Size) 1.500 (2)
Ask (Size) 1.580 (57)
Prev. Close 1.490
Today's Range 1.440 - 1.540
52wk Range 1.150 - 9.970
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Small-Caps Explode Higher As Tariff Fears Ease: Humacyte, Forward Air, FormFactor Top Russell 2000
Trump's tariff delay caused the small-cap stocks in iShares Russell 2000 ETF to rise significantly. Semiconductor components were also top performers. 
Via Benzinga
Topics ETFs Government World Trade
Exposures Political Tariff
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish
Fourth-quarter loss per share came in at $0.16, lower than the $0.24 in the corresponding period of 2023, and below the consensus estimate of $0.25, according to FinChat data. 
Via Stocktwits
Topics Earnings
Exposures Financial Product Safety

Performance

YTD
-70.3%
-70.3%
1 Month
-48.8%
-48.8%
3 Month
-64.9%
-64.9%
6 Month
-72.8%
-72.8%
1 Year
-46.3%
-46.3%

More News

Read More
Earnings Scheduled For March 28, 2025
Via Benzinga
Humacyte Earnings Preview
Via Benzinga
These stocks are moving in today's session
Via Chartmill
Keep an eye on the top gainers and losers in Wednesday's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Why Humacyte (HUMA) Stock Is Falling Sharply
Via Benzinga
Top movers in Wednesday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert
Via Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Top movers in Tuesday's after hours session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Humacyte Shares Plunge After Hours: Here's Why
Via Benzinga
Trestle Bio Announces Research Collaboration with Humacyte
From Trestle Biotherapeutics, Inc.
Via Business Wire
HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Faruqi & Faruqi Reminds Humacyte Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA
From Faruqi & Faruqi LLP
Via GlobeNewswire
HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Deadline Soon: Humacyte, Inc. (HUMA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
HUMA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA
From The Rosen Law Firm PA
Via GlobeNewswire

Frequently Asked Questions

Is Humacyte, Inc. - Common Stock publicly traded?
Yes, Humacyte, Inc. - Common Stock is publicly traded.
What exchange does Humacyte, Inc. - Common Stock trade on?
Humacyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Humacyte, Inc. - Common Stock?
The ticker symbol for Humacyte, Inc. - Common Stock is HUMA on the Nasdaq Stock Market
What is the current price of Humacyte, Inc. - Common Stock?
The current price of Humacyte, Inc. - Common Stock is 1.540
When was Humacyte, Inc. - Common Stock last traded?
The last trade of Humacyte, Inc. - Common Stock was at 04/15/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.